In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding. Elgendy IY. Ann Intern Med 2020;173:JC27.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elgendy IY. In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding. Ann Intern Med 2020;173:JC27.
PMID: 32926820